secwatch.observer — SEC 8-K summary
======================================

Issuer:     Atara Biotherapeutics, Inc. (ATRA)
CIK:        0001604464
Form:       8-K
Filed at:   2025-10-07T23:59:59+00:00
Accession:  0001193125-25-232117
Event type: other_material
Sentiment:  negative
Materiality: 0.55
Item codes: 2.05
LLM model:  deepseek-v4-flash:cloud@v2

Atara Biotherapeutics cuts ~29% of workforce, retains ~15 employees
-------------------------------------------------------------------

- Workforce reduction impacts about 29% of current employees; expects to complete by January 2026.
- Approximately $1.3 million in severance and related benefits anticipated.
- Roughly 50% of charges are salary continuation and 60-day notice wages under California WARN Act.
- Company retains about 15 employees for strategic priorities.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1604464/000119312525232117/0001193125-25-232117-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1604464/000119312525232117/d802811d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-232117

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer